872PPhase Ib study (COSMIC-021) of cabozantinib in combination with atezolizumab: Results of the dose escalation stage in patients (pts) with treatment-naïve advanced renal cell carcinoma (RCC).

Autor:	Agarwal, N1 (AUTHOR), Vaishampayan, U2 (AUTHOR), Green, M3 (AUTHOR), Nucci, F di3 (AUTHOR), Chang, P-Y4 (AUTHOR), Scheffold, C4 (AUTHOR), Pal, S5 (AUTHOR)
Zdroj:	Annals of Oncology. 2018 Supplement, Vol. 29, pN.PAG-N.PAG. 1p.
Databáze:	Academic Search Ultimate
Externí odkaz:	Zobrazit plný text záznamu